维普中文期刊产品整合服务
34篇 您的检索式:作者名="Ronco M G"
    题名 作者 年代 出处 被引量
1Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer显示文摘Arbyn M Ronco G Anttila A 0,,05:1
2Process performance of cervical screening programmes in Europe显示文摘Ronco G van Ballegooijen M Becker N 2009Eur J Cancer2009,45,15:1
3Toughened polystyrene nanoparticles through high-solids miniemulsion polymerization显示文摘Ronco L I Minari R J Passeggi Jr M C G 2015Chemical Engineering Journal2015,263,:1
4The clinical impact of using pl6jNK4 immunoehemistry in cervical histopathology and cy- tology: an update of recent developments 显示文摘Bergeren C Ronco G Reuschenbach M 2015Int J Cancer2015,136,12:1
5The clinical impact of using p16 immunochemistry in cervical histopathology and cytology: an update of recentdevelopments显示文摘Bergeron C Ronco G Reuschenbach M 2014Int J Cancer2014,12,3:1
6Trials comparing cytology with human papillomavirus screening显示文摘Arbyn M Ronco G Meijer CJ 2009Lancet Oncol2009,10,10:1
7Efficacy of HPV-based screening for prevention of invasive cervical cancer:follow-up of four European randomised controlled trials显示文摘Ronco G Dillner J Elfstrm K M 2014The Lancet2014,383,9916:1
8Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials显示文摘Ronco G Dillner J Elfstr?m K M 2014Lancet2014,383,9916:1
9Trials comparing cytology with human papillomavirus screening显示文摘Arbyn M Ronco G Meijer CJ 2009Lancet Oncol2009,10,10:1
10Process performance of cervical screening programmes in Europe 显示文摘Ronco G van Ballegooijen M Becker N 2009Eur J Cancer2009,45,15:1
11Evidence regard- ing human papillomavirus testing in secondary prevention of cervical cancer 显示文摘Arbyn M Ronco G Anttila A 2012Vaccine2012,30,5:1
12Evidence regarding human papillomavirus testing in secondary prevention of cervicalcancer 显示文摘ARBYN M RONCO G ANTYILA A 2012Vaccine2012,30,5:1
13Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epi- dermal growth factor 显示文摘PIEDAGNEL R MURPHY G RONCO P M 1999J Biol Chem1999,274,3:1
14Health technology assessment report:HPV DNA based primary screening for cervical cancer precursors 显示文摘Ronco G Biggeri A Confortini M 2012Epidemiol Prev2012,36,34:1
15Trials comparing cytology with human papillomavirus screening显示文摘M Arbyn G Ronco CJLM Meijer P Naucler 2009Lancet Oncology2009,,10:1
16Evidence regarding human papillomavirns testing in secondary prevention of cervical cancer 显示文摘ARBYN M RONCO G ANTTILA A 2012Vaccine2012,30,5:1
17Chlamydia pneumoniae infection as a risk factor for accelerated atherosclerosis in hemodialysis patients显示文摘Schiavoni G Di Pietro M Ronco C 2010J Biol Regul Homeost Agents2010,24,3:1
18Identification of the critical oxygen delivery for anaerobic metabolism in humans显示文摘RONCO J J FENWICK J C TWEEDDALE M G 1993JAMA1993,270,13:1
19Efficacy of HPVbased screening for prevention of invasive cervical cancer:follow-up of four European randomised controlled trials显示文摘Ronco G Dillner J Elfstrom K M 2014Lancet2014,383,9916:1
20Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis显示文摘GM Clifford S Gallus R Herrero N Mu?oz PJF Snijders S Vaccarella PTH Anh C Ferreccio NT Hieu E Matos M Molano R Rajkumar G Ronco S de Sanjosé HR Shin S Sukvirach JO Thomas S Tunsakul CJLM Meijer S Franceschi The Lancet0,,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费